Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 509-512

  Kondratov, Alexander ^a   Stoliar, L A ^a   Kvasha, S M ^a   Gordiyuk, V V ^a   Zgonnyk, Y M ^b   Gerashchenko, A V ^a   Vozianov, A F ^b   Rynditch, A V ^a   Zabarovsky, E R ^c   Kashuba, V I ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Clear cell renal cell carcinoma; DNA methylation; Tumor suppressor gene

Indexed keywords

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE INACTIVATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LRRC3B GENE; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

CARCINOMA, RENAL CELL; DNA METHYLATION; HUMANS; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC;

EID: 84855692826     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.681     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. Cancer J Clin 60: 277-300, 2010.
2. Eble JN, Sauter G, Epstein JI, et al (eds): Pathology and Genetics of Tumors of theUrinary System and Male Genital Organs. World Health Organization Classification of Tumors. p7, 2004.
3. Arai E and Kanai Y: Genetic and epigenetic alterations during renal carcinogenesis. Int J Clin Exp Pathol 4, 58-73, 2011.
4. Crossey PA, Foster K, Richards FM et al: Molecular genetic investigations of the mechanism of tumorigenesis in von Hippel.Lindau disease: analysis of allele loss in VHL tumors. Hum Genet 93: 53-58, 1994. (Pubitemid 24016732)
5. Li J, Wang F, Haraldson K, et al: Functional characterization of the candidate tumor-suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res 64: 6438-6443, 2004. (Pubitemid 39297898)
6. Kashuba VI, Li J, Wang F, et al: RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci USA 101: 4906-4911, 2004. (Pubitemid 38469176)
7. Klein G, Imreh S and Zabarovsky ER: Why do we not all die of cancer at an early age? Adv Cancer Res 98: 1-16, 2007. (Pubitemid 46551248)
8. Morrissey C, Martinez A, Zatyka M, et al: Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 61: 7277-7281, 2001. (Pubitemid 32946526)
9. Ying J, Poon FF, Yu J et al: DLEC1 is a functional 3p22.3 tumor suppressor silenced by promoter CpG methylation in colon and gastric cancers. Br J Cancer 100: 663-669, 2009.
10. Kvasha S, Gordiyuk V, Kondratov A, Ugryn D, Zgonnyk YM, Rynditch AV and Vozianov AF: Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas. Cancer Lett 265: 250-257, 2008.
11. Dreijerink K, Braga E, Kuzmin I, et al: The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98: 7504-7509, 2001. (Pubitemid 32567978)
12. Skrypkina IYa, Kashuba VI, Gordiyuk VV, et al: Identification of changes in gene loci potentially associated with renal cancer by novel technique of NotI microarrays. Ukr Biokhim Zh 11: 188-192, 2006
13. Sambrook J, Fritsch EF and Maniatis T (eds): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, NY, p181, 1989.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
15. Spiess AN, Feig C and Ritz C: Highly accurate sigmoidal fitting of real-time PCR data by introducing a parameter for asymmetry BMC Bioinformatics 9: 221-233, 2008.
16. Kim M, Kim JH, Jang HR, et al: LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor- suppressor gene in gastric cancer. Cancer Res 68: 7147-7155, 2008.
17. Clark HF, Gurney AL, Abaya E, et al: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 13: 2265-2270, 2003. (Pubitemid 37265992)
18. Mittal S, Aslam A, Doidge R, Medica R and Winkler GS: The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4-Not complex contribute to the prevention of cell death and senescence. Mol Biol Cell 22: 748-758, 2011.
19. Xu ZM, Gao WR, Mei Q, Chen J and Lu J: The novel gene LRP15 is regulated by DNA methylation and confers increased efficiency of DNA repair of ultraviolet-induced DNA damage. BMB Rep 41: 230-235, 2008. (Pubitemid 351518996)
20. Tian XQ, Zhang Y, Sun D, Zhao S, Xiong H and Fang J: Epigenetic silencing of LRRC3B in colorectal cancer. Scand J Gastroenterol 44: 79-84, 2009.
21. Dou LP, Wang C, Xu ZM, Kang HY, Fan H, Lou FD and Yu L: Methylation pattern of LRP15 gene in leukemia. Chin Med Sci J 22: 187-191, 2007. (Pubitemid 47572132)
22. Dunwell TL, Hesson LB, Pavlova T, et al: Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 4, 185-193, 2009.
23. Gordiyuk VV, Gerashchenko GV, Skrypkina IYa, et al: Identification of chromosome 3 epigenetic and genetic abnormalities and gene expression changes in ovarian cancer. Biopolymers Cell 24: 323-332, 2008.
24. Gerashchenko GV, Gordiyuk VV, Skrypkina IYa et al: Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr Biokhim Zh 81: 81-87, 2009